Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>>NEW! Download now...

Boston Scientific Starts China Trial of New Stent

publication date: Jan 27, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Boston Scientific has started a China trial of its Promus™ drug eluting stent. The double-blind test will enroll 500 patients in 15 sites across China. The goal of the trial, which is the first that Boston Scientific has conducted entirely within China, is to gain SFDA approval of the device. More details....

Stock Symbol: (NYSE: BSX)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events


BioPacific Conference 2012
June 2, 2012
California, USA

  China Forum 2012
  November 11, 2012
Hamburg, Germany

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners